pcos semaglutide and metformin improve menstrual cyclicity in overweight/obese women with polycystic ovary syndrome: a randomized trial PCOS Weight Loss Journey: 12
Description
Retatrutide is the first triple-agonist medicine being developed for obesity and weight loss
The day of weekly administration can be changed, if necessary, as long as the time between the 2 doses is at least 3 days (72 hours)
A study utilizing a national database found that individuals treated with GLP-1 receptor agonists had a significantly lower risk of developing glaucoma compared to those who were not on these medications
Any compounded drugs prescribed are based on a licensed providers medical judgement based on a telehealth encounter and medical history.
currently India has the second highest number of diabetes cases in the world preceded only by China [1]
Medical assisted wellness programs go beyond diet and exercise
